Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ubiquitin specific peptidase 2 | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | ubiquitin specific protease, putative | ubiquitin specific peptidase 2 | 362 aa | 378 aa | 25.7 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0406 | 0.7418 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0406 | 0.7408 | 0.7408 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0212 | 0.2592 | 0.1204 |
Giardia lamblia | GTOR | 0.051 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0305 | 0.4901 | 0.4901 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0406 | 0.7418 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0342 | 0.5829 | 0.5829 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.051 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0331 | 0.5555 | 0.5555 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4171 | 0.4171 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0171 | 0.1579 | 0.1579 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.051 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0305 | 0.4901 | 0.4901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0241 | 0.3322 | 0.207 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0137 | 0.0729 | 0.0729 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0406 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4161 | 0.4161 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0305 | 0.4901 | 0.4901 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.051 | 1 | 0.5 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.051 | 1 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.051 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.051 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.051 | 1 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0406 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0406 | 0.7408 | 0.7408 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.051 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.051 | 1 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0379 | 0.6753 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0435 | 0.8147 | 0.8147 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0171 | 0.1579 | 0.1579 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0379 | 0.6753 | 0.6753 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0406 | 0.7408 | 0.7408 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0302 | 0.4826 | 0.4826 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4161 | 0.4161 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0406 | 0.7418 | 0.6934 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.051 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0275 | 0.4171 | 0.4171 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0302 | 0.4826 | 0.4826 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 44.6684 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.